Arbutus Biopharma says FDA lifts clinical hold on AB-101 IND

Arbutus Biopharma said the FDA has lifted the clinical hold on the AB-101 IND, allowing the company to engage in additional clinical development for AB-101 in the US.

Detected & updated continuously · Source: Nebula